| Literature DB >> 34007136 |
Peng Liu1, Xian-Zhen Tan1, Ting Zhang2, Qian-Biao Gu1, Xian-Hai Mao3, Yan-Chun Li4, Ya-Qiong He5.
Abstract
BACKGROUND: Liver cancer is one of the most common malignant tumors, and ranks as the fourth leading cause of cancer death worldwide. Microvascular invasion (MVI) is considered one of the most important factors for recurrence and poor prognosis of liver cancer. Thus, accurately identifying MVI before surgery is of great importance in making treatment strategies and predicting the prognosis of patients with hepatocellular carcinoma (HCC). Radiomics as an emerging field, aims to utilize artificial intelligence software to develop methods that may contribute to cancer diagnosis, treatment improvement and evaluation, and better prediction. AIM: To investigate the predictive value of computed tomography radiomics for MVI in solitary HCC ≤ 5 cm.Entities:
Keywords: Computed tomography; Hepatocellular carcinoma; Image features; Microvascular invasion; Radiomics
Mesh:
Year: 2021 PMID: 34007136 PMCID: PMC8108034 DOI: 10.3748/wjg.v27.i17.2015
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742
Figure 1Screening process for patients with liver cancer. HCC: Hepatocellular carcinoma; CT: Computed tomography; MVI: Microvascular invasion.
Figure 2Specific performance of two-trait predictor of venous invasion and radiogenomic invasion. A and B: The discriminant process of two-trait predictor of venous invasion (TTPVI) (A) and radiogenomic invasion (RVI) (B); C: Negative intratumoral arteries: Negative TTPVI and RVI; D: Positive intratumoral arteries and peritumoral low density: Negative TTPVI and PVI; E: Positive intratumoral arteries, negative peritumoral low-density shadow, and positive tumor-liver differences: Positive TTPVI and negative RVI; F: Positive intratumoral arteries, negative peritumoral low density, and negative tumor-liver differences: Positive TTPVI and RVI. TTPVI: Two-trait predictor of venous invasion; RVI: Radiogenomic invasion.
Clinical and imaging features of patients in the training group and verification group
|
|
|
|
|
|
| Age (yr), median (quartile) | 54 (47; 63) | 52 (46; 62) | -0.900 | 0.368 |
| Gender/cases | ||||
| Male | 102 | 53 | 0.349 | 0.555 |
| Female | 22 | 8 | ||
| Hepatitis B | 104 | 56 | 1.575 | 0.210 |
| Liver cirrhosis | 84 | 43 | 0.044 | 0.833 |
| AFP (ng/mL) | ||||
| ≤ 20 | 73 | 30 | 1.188 | 0.276 |
| > 20 | 51 | 31 | ||
| MVI | ||||
| Negative | 82 | 40 | 0.000 | 1.000 |
| Positive | 42 | 21 | ||
| Tumor size (mm), median (quartile) | 36 (28; 44) | 34 (27.5; 41) | -0.746 | 0.456 |
| TTPVI | ||||
| Negative | 56 | 25 | 0.145 | 0.703 |
| Positive | 68 | 36 | ||
| RVI | ||||
| Negative | 93 | 40 | 1.362 | 0.243 |
| Positive | 31 | 21 | ||
| Rad-score, median (quartile) | -0.669 (-0.831; -0.546) | -0.640 (-0.780; -0.494) | -0.917 | 0.359 |
AFP: α-fetoprotein; MVI: Microvascular invasion; TTPVI: Two-trait predictor of venous invasion; RVI: Radiogenomic invasion; Rad-score: Radiomics score.
Figure 3Selection of radiomic features using the least absolute shrinkage and selection operator-logistic regression model. A: Coefficient profile of 158 radiomics features against the area under the curve; B: Cross-validation curve. Red dotted vertical lines are drawn at the optimal log (Lambda) by using 10-fold cross-validation and the 1-SE criteria. Ten nonzero coefficients are chosen. AUC: Area under the curve.
Comparison of predictive performance between radiomics tags and image features
|
|
|
| ||
|
|
|
|
| |
| Rad-score | 0.724 (0.584-0.863) | 0.745 (0.655-0.834) | ||
| TTPVI | 0.590 (0.500-0.679) | 0.522 (0.393-0.651) | ||
| RVI | 0.545 (0.462-0.628) | 0.528 (0.401-0.655) | ||
| Rad | 0.018 | 0.043 | ||
| Rad | 0.002 | 0.048 | ||
AUC: Area under the curve; CI: Confidence interval; TTPVI: Two-trait predictor of venous invasion; RVI: Radiogenomic invasion; Rad-score: Radiomics score.
Figure 4The two-trait predictor of venous invasion (green curve), radiogenomic invasion (red curve), and receiver operator characteristic of radiomics tag (blue curve) from the two groups. A: Training group; B: Verification group. TTPVI: Two-trait predictor of venous invasion; RVI: Radiogenomic invasion.